📰 Cell Stem News
Page 27 - Cell Stem News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Stem. Real-time updates on events, politics, business and more.
February 25, 2022
Researchers from the Babraham Institute have today published their latest work in the journal Cell Stem Cell describing a new subset of human embryonic stem cells that closely resemble the cells present at the genomic 'wake up call' of the 8-cell embryo stage in humans.
February 10, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
February 9, 2022
Lund, February 9, 2022 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced it has entered into an exclusive license agreement with Oncode Institute in the Netherlands, for the global rights to patents
February 9, 2022
Investegate announcements from Active Biotech, Active Biotech enters into global patent license agreement with Oncode Institute for tasquinimod in myelofibrosis
February 9, 2022
Lund, February 9, 2022 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced it has entered into an exclusive license agreement with Oncode Institute...
January 24, 2022
A handful of experiments are raising questions about whether clumps of cells and disembodied brains could be sentient and how scientists would know if they were
January 24, 2022
Neuroscientists face a paradox. The field aims to understand the mysteries of the human mind, but studying the actual human brain cells and circuits that produce our mental lives—and how they go awry in neuropsychiatric disease—is incredibly challenging. After all, the brain is packed away carefully in our skulls, and people typically don’t part with samples of their brain
January 21, 2022
The measure would require health care providers to inform patients and get written consent acknowledging that stem cell therapies theyre seeking have not been approved by the FDA.
January 19, 2022
The gene TRAF6 can block progression from pre-leukemia to full-blown disease, say researchers. But research is still in the early stages and potential therapies and clinical trials may be years away.
January 10, 2022
The disruption of gene transcription and cell function in Down syndrome is very similar to that seen in cellular aging, MIT scientists find. They used anti-senescence drugs to correct the errors in cell cultures, establishing senescence as a potentially targetable mechanism for future treatment.